UBS: Meta Product Advantages Remain, AI Monetization Potential Undervalued, Maintain Buy Rating

Overview

This report is UBS's commentary on Meta Platforms (META)'s Q1 2026 earnings. The report notes that Meta achieved double beats on revenue and earnings per share in the first quarter, mainly benefiting from strong recovery in ad impressions and improvement in AI recommendation engines. However, management raised 2026 capital expenditure guidance, causing analysts to downgrade earnings per share expectations for the next two years. Nevertheless, UBS believes the market has only factored operating expenses and capital expenditures into models, failing to fully price the comprehensive revenue dividends brought by AI, thus Meta's product development advantages still lead current valuations. Based on this, UBS maintains 'Buy' rating and lowers target price from $908 to $865.

Core views

Meta 1Q26 earnings performance was strong, reaching $56.3 billion in revenue, exceeding UBS estimates of $55.9 billion and market consensus of $55.5 billion; diluted Earnings Per Share (EPS) was $10.44, far exceeding expected $7.19 and consensus of $6.68. This beat was mainly attributed to Ad Impressions growing 19% YoY, accelerating from 18% last quarter, with broad growth momentum across verticals. Additionally, Other Income (including Reality Labs) also grew 14% due to sales of Meta collaboration glasses. Regarding financial forecast adjustments, while revenue forecasts were revised upward (2026, 2027, and 2028 revenue forecasts adjusted to $252.3 billion, $309.4 billion, and $361.0 billion respectively), cost-side pressures increased significantly. Management raised 2026 Capital Expenditure (CapEx) guidance to $125 billion-$145 billion (previously $115 billion-$135 billion), and Total Expense guidance remained at high levels. Affected by this, UBS lowered 2026, 2027, and 2028 GAAP Diluted EPS forecasts, down to $32.67, $32.98, and $34.98 respectively. Based on an unchanged 26x 2027 P/E multiple, the target price was accordingly lowered from $908 to $865. The report elaborates on the bull-bear battle logic. Bull arguments believe the strong 1Q26 performance validates the sustainability of ad impression growth, and signs of Business AI growth mentioned by management indicate GenAI revenue streams are materializing, providing confidence to investors. Bears worry the midpoint of 2Q26 revenue guidance matches market expectations with no surprise in unlocking GenAI revenue, and high capital expenditure may continue to squeeze profits. UBS believes current optimism stems more from reactions to recent trading and product announcements among megacap peers, while Meta's uniqueness lies in its comprehensive revenue-side benefits not being fully determined, offering multiple options and valuation upside space.

Analysis framework

UBS's analysis logic is built on 'supply-demand and valuation mismatch'. First, by breaking down revenue drivers (Price vs Quantity), we found the recovery of ad impressions was the core reason for beating expectations, reflecting the recovery of user engagement. Second, Scenario Analysis was used to assess asymmetry of risk and return: Base scenario assumes 2-year Revenue CAGR of 22%, Operating Margin 32%; Upside scenario assumes CAGR accelerates to 26%, Margin improves to 34%; Downside scenario assumes CAGR slows to 20%, Margin compresses to 26%. This analysis method clearly shows the impact of different operating leverage on stock price under a given valuation multiple. Finally, combined with Relative Valuation, using 26x P/E (one standard deviation higher than long-term average) for pricing, reasoning that this multiple includes option value for AI-driven market share gains, and also reflects reality where new revenue streams have not yet contributed large-scale profits, leading to a prudent but optimistic valuation conclusion.

Methodology notes

• Industry/Industrial Analysis FrameworkSupply-demand framework

  Volume-Price Split Analysis of Ad Market

  The research report breaks down ad revenue into 'Ad Impressions' and 'Price Per Ad' dimensions. By observing the shift in impressions from negative growth to positive growth (+19% YoY), we judge the recovery of demand-side sentiment (user engagement and content consumption), which is the core fundamental evidence supporting revenue growth.

• Valuation MethodPE Valuation

  Absolute Valuation and Scenario Analysis Based on Forward P/E

  The report uses forward P/E for valuation, selecting 26x as target multiple (reasoning: one standard deviation above long-term mean, reflecting option value of AI growth). Combined with different assumptions for Revenue CAGR and Operating Margin, it derives target stock prices for Up, Base, and Down scenarios to quantify potential risk-reward skew.

• Event Gambling and Behavioral FinanceExpectation Gap/Expectation Management

  Lag in Market Reaction to Good News and Repricing Logic

  The report points out that although peer stock prices benefited from product announcements, Meta's stock reaction was relatively restrained. Analysts believe the market has currently only factored in increases on the cost side (CapEx/OpEx), without fully pricing in potential explosions on the revenue side. This 'partial pricing' state constitutes an expectation gap, meaning actual fundamental improvement may exceed current implicit market expectations, bringing momentum for upward correction in stock price.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• META (META.US)

  Directly benefits from AI-driven ad efficiency improvements and impression growth, core coverage target of UBS.

  Strengths

  Possesses massive user base and mature advertising ecosystem; AI recommendation engine improvements significantly boost content distribution efficiency; Business AI and Consumer AI chatbots open up new ad inventory (e.g., search ads) and monetization channels.

  Weaknesses

  Reality Labs continues to lose money with uncertain output; High capital expenditure (CapEx) plan puts pressure on short-term margins; Regulatory environment and iOS policy changes remain potential external risks.

  Comparison

  Compared to TikTok and Snap, Meta integrates its existing social graph and messaging system with AI, possessing richer ad scenarios and data loops; Compared to other tech giants, Meta's AI monetization path in the ad field is more immediate and measurable.

  Risks

  Overall ad market decline; iOS privacy policies restrict targeting effectiveness; Intensified antitrust regulation; AI investment ROI lower than expected; User growth or participation stagnation.

Key data

• 1Q26 Revenue$56.3 billionExceeded YoY expectations, where ad impressions grew 19% YoY
• 1Q26 Diluted EPS$10.44Significantly exceeded expectations (Est $7.19, Consensus $6.68)
• 2026 Capital Expenditure (CapEx) Guidance$125 billion-$145 billionRaised $10 billion above prior guidance cap, leading to EPS forecast downgrade
• 2027 Target P/E26xOne standard deviation above Meta long-term average
• Target Price$865Implies approx 29%-40% upside space vs current stock price

Impact & implications

For investors, this report indicates Meta is in a key phase transitioning from 'Cost Investment Period' to 'Revenue Realization Period'. Although high capital expenditure will suppress margins and lead to EPS forecast downgrade in the short term, strong recovery of ad fundamentals (especially impression rebound) and potential of AI products in improving ad efficiency and expanding search ads provide solid support for long-term growth. The report implies current stock price does not fully reflect full-platform monetization potential driven by AI. If subsequent quarters can prove scale capabilities of GenAI revenue streams, valuation could expand further. Conversely, if capital expenditure remains high while revenue growth falls short of expectations, downside risks exist.

Risks

• Revenue decline caused by overall ad market weakness
• Continuous impact of iOS system changes on ad targeting and measurement
• Changes in regulatory environment and reinterpretation of antitrust laws
• Erosion of user growth and engagement by competitors like TikTok
• User shift to low-monetization areas (e.g., Reels), with uncertainty in long-term monetization potential of new formats
• Uncertain results of heavy investment in Reality Labs, and currently lacking clear product-market fit

What to watch

• Actual scaling and monetization progress of GenAI revenue streams (especially related to Business AI and Consumer AI ads)
• Matching efficiency between Capital Expenditure (CapEx) investment and actual capacity/revenue growth
• Continuing sequential improvement trend of Ad Impressions and Price Per Ad
• Adjustments by management to future quarterly revenue guidance, especially whether there appears to be a GenAI unlocking effect exceeding current expectations